
Proposed regulatory reform of 648/96 for fast access to orphan drugs
Rome, 31 January 2023. The following text summarises the speech by Valeria Viola, owner of Pharma Value, during the presentation of the 6th OSSFOR Annual Report

Rome, 31 January 2023. The following text summarises the speech by Valeria Viola, owner of Pharma Value, during the presentation of the 6th OSSFOR Annual Report

On 19 and 20 May, the 1st GIRF Congress - ISPOR Roma for Future Group - was held in Naples, recognising the importance of collaboration between

Being aware of the right value of a drug is a conviction that has inspired Pharma Value's actions, right from the choice of the name, as well as

On 30 December 2020 AIFA approved the document containing the provisions required by art. 2 of Ministerial Decree of 2 August 2019, 'Criteria and procedures

The AIFA Guidelines for the compilation of the dossier supporting the application for the reimbursability and pricing of a medicine have finally been published

In this time of COVID-19 emergency, one often hears about 'Compassionate Use' The DM 7/9/2017 regulates the free supply by pharmaceutical companies